Figure 3.
Outcomes in lymphoid malignancies. HR of OS in lymphoid malignancies (A) and funnel plot (B). HR of progression-free survival in lymphoid malignancies (C) and funnel plot (D). ALL, acute lymphoblastic leukemia; BCL, B-cell lymphoma; DLBCL, diffuse large B-cell lymphoma; ENKTL, extranodal natural killer/T-cell lymphoma; FL, follicular lymphoma; HL, Hodgkin lymphoma; MCL, mantle cell lymphoma; NHL, non-Hodgkin lymphoma; R, rituximab; seTE, standard error of treatment estimate; TCL, T-cell lymphoma; TE, estimated treatment effect.

Outcomes in lymphoid malignancies. HR of OS in lymphoid malignancies (A) and funnel plot (B). HR of progression-free survival in lymphoid malignancies (C) and funnel plot (D). ALL, acute lymphoblastic leukemia; BCL, B-cell lymphoma; DLBCL, diffuse large B-cell lymphoma; ENKTL, extranodal natural killer/T-cell lymphoma; FL, follicular lymphoma; HL, Hodgkin lymphoma; MCL, mantle cell lymphoma; NHL, non-Hodgkin lymphoma; R, rituximab; seTE, standard error of treatment estimate; TCL, T-cell lymphoma; TE, estimated treatment effect.

Close Modal

or Create an Account

Close Modal
Close Modal